Nectar Lifesciences Limited

NSEI:NECLIFE Rapporto sulle azioni

Cap. di mercato: ₹8.9b

Nectar Lifesciences Performance dei guadagni passati

Il passato criteri di controllo 2/6

Nectar Lifesciences's earnings have been declining at an average annual rate of -20.7%, while the Pharmaceuticals industry saw earnings growing at 13.4% annually. Revenues have been declining at an average rate of 11.4% per year. Nectar Lifesciences's return on equity is 0.6%, and it has net margins of 0.4%.

Informazioni chiave

-20.7%

Tasso di crescita degli utili

-20.7%

Tasso di crescita dell'EPS

Pharmaceuticals Crescita del settore17.5%
Tasso di crescita dei ricavi-11.4%
Rendimento del capitale proprio0.6%
Margine netto0.4%
Prossimo aggiornamento sui guadagni14 Nov 2024

Aggiornamenti sulle prestazioni recenti

Recent updates

Revenues Working Against Nectar Lifesciences Limited's (NSE:NECLIFE) Share Price Following 26% Dive

Oct 11
Revenues Working Against Nectar Lifesciences Limited's (NSE:NECLIFE) Share Price Following 26% Dive

Nectar Lifesciences Limited (NSE:NECLIFE) Shares Fly 31% But Investors Aren't Buying For Growth

Aug 22
Nectar Lifesciences Limited (NSE:NECLIFE) Shares Fly 31% But Investors Aren't Buying For Growth

Here's Why Nectar Lifesciences (NSE:NECLIFE) Has A Meaningful Debt Burden

Jul 27
Here's Why Nectar Lifesciences (NSE:NECLIFE) Has A Meaningful Debt Burden

Nectar Lifesciences Limited (NSE:NECLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Feb 19
Nectar Lifesciences Limited (NSE:NECLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?

Dec 22
Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?

Nectar Lifesciences (NSE:NECLIFE) Has Debt But No Earnings; Should You Worry?

Jun 16
Nectar Lifesciences (NSE:NECLIFE) Has Debt But No Earnings; Should You Worry?

Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt

Jun 21
Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt

Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt

Jul 29
Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt

Is Nectar Lifesciences Limited (NSE:NECLIFE) A Risky Dividend Stock?

Feb 25
Is Nectar Lifesciences Limited (NSE:NECLIFE) A Risky Dividend Stock?

Nectar Lifesciences (NSE:NECLIFE) Has A Somewhat Strained Balance Sheet

Jan 21
Nectar Lifesciences (NSE:NECLIFE) Has A Somewhat Strained Balance Sheet

Zooming in on NSE:NECLIFE's 0.3% Dividend Yield

Nov 02
Zooming in on NSE:NECLIFE's 0.3% Dividend Yield

Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?

Sep 07
Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?

If You Had Bought Nectar Lifesciences (NSE:NECLIFE) Stock A Year Ago, You Could Pocket A 47% Gain Today

Aug 09
If You Had Bought Nectar Lifesciences (NSE:NECLIFE) Stock A Year Ago, You Could Pocket A 47% Gain Today

The Nectar Lifesciences (NSE:NECLIFE) Share Price Has Gained 47% And Shareholders Are Hoping For More

Aug 09
The Nectar Lifesciences (NSE:NECLIFE) Share Price Has Gained 47% And Shareholders Are Hoping For More

What You Can Learn From Nectar Lifesciences Limited's (NSE:NECLIFE) P/E

Jul 13
What You Can Learn From Nectar Lifesciences Limited's (NSE:NECLIFE) P/E

Ripartizione dei ricavi e delle spese

Come Nectar Lifesciences guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.


Storia dei guadagni e delle entrate

NSEI:NECLIFE Ricavi, spese e utili (INR Millions )
DataRicaviGuadagniSpese G+ASpese di R&S
30 Jun 2416,493619180
31 Mar 2416,846508660
31 Dec 2316,322818290
30 Sep 2315,241-288100
30 Jun 2315,148-2637970
31 Mar 2315,237-2427960
31 Dec 2216,120-1627890
30 Sep 2217,109287850
30 Jun 2216,8682727490
31 Mar 2216,6892507630
31 Dec 2115,421-2768570
30 Sep 2114,765-4548680
30 Jun 2115,387-5467420
31 Mar 2115,433-7338720
31 Dec 2017,586-2497650
30 Sep 2020,291-867760
30 Jun 2021,807128040
31 Mar 2023,6643188280
31 Dec 1925,9734198140
30 Sep 1926,8194468090
30 Jun 1928,2744807980
31 Mar 1927,8294768120
31 Mar 1818,7635237980
31 Mar 1716,4375538060
31 Mar 1616,7575428320
31 Mar 1516,4366636390
31 Mar 1416,3836219380

Guadagni di qualità: NECLIFE has high quality earnings.

Margine di profitto in crescita: NECLIFE became profitable in the past.


Flusso di cassa libero e analisi degli utili


Analisi della crescita degli utili nel passato

Andamento degli utili: NECLIFE's earnings have declined by 20.7% per year over the past 5 years.

Accelerare la crescita: NECLIFE has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Guadagni vs Settore: NECLIFE has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (19.1%).


Rendimento del capitale proprio

ROE elevato: NECLIFE's Return on Equity (0.6%) is considered low.


Rendimento delle attività


Rendimento del capitale investito


Scoprire le aziende con forti performance passate